Morphogenic protein-specific cell surface receptors and uses therefor
AssigneesCurtis, Inc., Ludwig Institute for Cancer Research
InventorsPeter ten Dijke, Carl-Henrik Heldin, Kohei Miyazono, Kuber T. Sampath
Life of this patent
Estimating the term…
Loading patent…
AssigneesCurtis, Inc., Ludwig Institute for Cancer Research
InventorsPeter ten Dijke, Carl-Henrik Heldin, Kohei Miyazono, Kuber T. Sampath
Estimating the term…
Disclosed are (1) nucleic acid sequences, amino acid sequences, homologies, structural features and various other data characterizing a morphogen cell surface receptors particularly OP-1-binding cell surface receptors ALK-2, ALK-3, and ALK-6; (2) methods for producing receptor proteins, including fragments thereof, using recombinant DNA technology; (3) methods for identifying novel morphogen receptors and their encoding DNAS; (4) methods and compositions for identifying compounds capable of modulating endogenous morphogen receptor levels; and (5) methods and compositions for identifying morphogen receptor binding analogs useful in the design of morphogen agonists and antagonists for therapeutic, diagnostic and experimental uses.
A method for identifying an OP-1 analog having the same binding affinity for a cell surface receptor as OP-1, the method comprising the steps of:
A kit for identifying OP-1 or a candidate OP-1 analog in a sample, the kit comprising:
Dependencies are inferred from the claim text.